Education
About Us
Working with TipRanks
Follow Us
Entero Therapeutics (ENTO)
NASDAQ:ENTO
Entero Therapeutics (ENTO) Ownership Overview
The ownership structure of Entero Therapeutics (ENTO) stock is a mix of institutional, retail, and individual investors. , 1.09% is owned by Insiders, and 97.82% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
Jan 08, 2025 | xxxxxxxxxxxxx | $465 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,287 | Insider | 1.09% | 64,481 | |
| 12,115 | Institution | 0.76% | 45,189 | |
| 5,301 | Institution | 0.33% | 19,773 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 12,115 | Institution | 0.76% | 45,189 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,301 | Institution | 0.33% | 26,505 |
FAQ
Who Owns Entero Therapeutics (ENTO)?
Currently, no data Available
What percentage of Entero Therapeutics (ENTO) stock is held by institutional investors?
Currently, no data Available
What percentage of Entero Therapeutics (ENTO) stock is held by retail investors?
According to the latest TipRanks data, approximately 97.82% of Entero Therapeutics (ENTO) stock is held by retail investors.
Who owns the most shares of Entero Therapeutics (ENTO)?
Sarah Romano owns the most shares of Entero Therapeutics (ENTO).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.